XOMAO Latest News, Press Relases and Analysis

All

Press Releases

3 days ago - By: XOMA Royalty Corporation - Mentions: XOMA

XOMA Royalty Reports Third Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements

3 days ago - By: XOMA Royalty Corporation - Mentions: XOMA

XOMA Royalty Reports Third Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements

a month ago - By: XOMA Royalty Corporation; LAVA Therapeutics N.V. - Mentions: XOMA

XOMA Royalty and LAVA Therapeutics Announce Amendment to Purchase Agreement

a month ago - By: XOMA Royalty Corporation; LAVA Therapeutics N.V. - Mentions: XOMA LVTX

XOMA Royalty and LAVA Therapeutics Announce Amendment to Purchase Agreement

a month ago - By: XOMA Royalty Corporation; LAVA Therapeutics - Mentions: XOMA LVTX

XOMA Royalty Extends Tender Offer to Acquire LAVA Therapeutics N.V.

a month ago - By: XOMA Royalty Corporation; LAVA Therapeutics - Mentions: XOMA

XOMA Royalty Extends Tender Offer to Acquire LAVA Therapeutics N.V.

2 months ago - By: XOMA Royalty Corporation - Mentions: XOMA

XOMA Royalty Declares Quarterly Preferred Stock Dividends

2 months ago - By: XOMA Royalty Corporation - Mentions: XOMA

XOMA Royalty Declares Quarterly Preferred Stock Dividends

2 months ago - By: XOMA Royalty Corporation - Mentions: XOMA

XOMA Royalty Announces Closing of Tender Offer for HilleVax, Inc.

2 months ago - By: XOMA Royalty Corporation - Mentions: XOMA HLVX

XOMA Royalty Announces Closing of Tender Offer for HilleVax, Inc.

2 months ago - By: XOMA Royalty Corporation - Mentions: XOMA

XOMA Royalty to Present at H.C. Wainwright 27th Annual Global Investment Conference

2 months ago - By: XOMA Royalty Corporation - Mentions: XOMA

XOMA Royalty to Present at H.C. Wainwright 27th Annual Global Investment Conference

3 months ago - By: XOMA Royalty Corporation - Mentions: XOMA

Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share

3 months ago - By: XOMA Royalty Corporation - Mentions: XOMA

XOMA Royalty Reports Second Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements

3 months ago - By: XOMA Royalty Corporation - Mentions: XOMA

XOMA Royalty Reports Second Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements

3 months ago - By: XOMA Royalty Corporation - Mentions: XOMA

XOMA Royalty Announces Closing of Tender Offer for Turnstone Biologics

3 months ago - By: XOMA Royalty Corporation - Mentions: XOMA TSBX

XOMA Royalty Announces Closing of Tender Offer for Turnstone Biologics

3 months ago - By: XOMA Royalty Corporation; LAVA Therapeutics N.V. - Mentions: XOMA

XOMA Royalty Enters into Agreement to Acquire LAVA Therapeutics for Between $1.16 and $1.24 Per Share in Cash, Plus a Contingent Value Right

3 months ago - By: XOMA Royalty Corporation; LAVA Therapeutics N.V. - Mentions: XOMA LVTX

XOMA Royalty Enters into Agreement to Acquire LAVA Therapeutics for Between $1.16 and $1.24 Per Share in Cash, Plus a Contingent Value Right

3 months ago - By: XOMA Royalty Corporation - Mentions: XOMA

HilleVax Enters into a Definitive Agreement to be Acquired by XOMA Royalty for $1.95 in Cash per Share Plus a Contingent Value Right

3 months ago - By: XOMA Royalty Corporation - Mentions: XOMA HLVX

HilleVax Enters into a Definitive Agreement to be Acquired by XOMA Royalty for $1.95 in Cash per Share Plus a Contingent Value Right

5 months ago - By: XOMA Royalty Corporation; Turnstone Biologics Corp. - Mentions: XOMA

Turnstone Biologics Corp. Enters into Agreement to be Acquired by XOMA Royalty Corporation for $0.34 in Cash Per Share Plus a Contingent Value Right

5 months ago - By: XOMA Royalty Corporation; Turnstone Biologics Corp. - Mentions: XOMA TSBX

Turnstone Biologics Corp. Enters into Agreement to be Acquired by XOMA Royalty Corporation for $0.34 in Cash Per Share Plus a Contingent Value Right

5 months ago - By: XOMA Royalty Corporation - Mentions: XOMA

XOMA Royalty Declares Quarterly Preferred Stock Dividends

5 months ago - By: XOMA Royalty Corporation - Mentions: XOMA

XOMA Royalty Declares Quarterly Preferred Stock Dividends

6 months ago - By: XOMA Royalty Corporation; BioInvent - Mentions: XOMA

XOMA Royalty Purchases Mezagitamab Royalty and Milestone Rights Held by BioInvent International for up to USD $30 Million

6 months ago - By: XOMA Royalty Corporation; BioInvent - Mentions: XOMA

XOMA Royalty Purchases Mezagitamab Royalty and Milestone Rights Held by BioInvent International for up to USD $30 Million

6 months ago - By: XOMA Royalty Corporation - Mentions: XOMA

XOMA Royalty Reports First Quarter 2025 Financial Results and Highlights Business Achievements

6 months ago - By: XOMA Royalty Corporation - Mentions: XOMA

XOMA Royalty Reports First Quarter 2025 Financial Results and Highlights Business Achievements

6 months ago - By: XOMA Royalty Corporation - Mentions: XOMA

XOMA Royalty to Present at H.C. Wainwright 1st Annual Royalty Company Virtual Conference

6 months ago - By: XOMA Royalty Corporation - Mentions: XOMA

XOMA Royalty to Present at H.C. Wainwright 1st Annual Royalty Company Virtual Conference

7 months ago - By: XOMA Royalty Corporation - Mentions: XOMA